Lung Cancers Completed Phase 1 / 2 Trials for Motesanib (DB05575)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT00094835Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Treatment